Cargando…
Platelet‐activating factor antagonist‐based intensive antiplatelet strategy in acute ischemic stroke: A propensity score matched with network pharmacology analysis
BACKGROUND: Diterpene ginkgolides meglumine injection (DGMI) is a platelet‐activating factor receptor (PAFR) antagonist that can be used to treat acute ischemic stroke (AIS). This study evaluated the efficacy and safety of an intensive antiplatelet strategy based on PAFR antagonists and explored the...
Autores principales: | Han, Xiaoyan, Li, Youjia, Chen, Xuemin, Pan, Dong, Mo, Junning, Qiu, Jiaming, Li, Yi, Chen, Yan, Huang, Yan, Shen, Qingyu, Tang, Yamei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651968/ https://www.ncbi.nlm.nih.gov/pubmed/37435773 http://dx.doi.org/10.1111/cns.14331 |
Ejemplares similares
-
Baseline Objective Malnutritional Indices as Immune-Nutritional Predictors of Long-Term Recurrence in Patients with Acute Ischemic Stroke
por: Han, Xiaoyan, et al.
Publicado: (2022) -
Antiplatelet therapy does not influence outcome or host response biomarkers during sepsis: a propensity-matched analysis
por: Wiewel, MA, et al.
Publicado: (2015) -
Anticoagulant or antiplatelet use and severe COVID-19 disease: A propensity score-matched territory-wide study
por: Zhou, Jiandong, et al.
Publicado: (2021) -
Antiplatelet Use in Ischemic Stroke
por: Kamarova, Marharyta, et al.
Publicado: (2022) -
Antiplatelet Aggregation and Platelet Activating Factor (PAF) Receptor Antagonistic Activities of the Essential Oils of Five Goniothalamus Species
por: Moharam, Bushra Abdulkarim, et al.
Publicado: (2010)